Published Oct 4, 2016 |
40 Pages |
Pub ID: KLI15123229
IVD in the Middle East (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast)
There's over a 2 billion-dollar opportunity for in vitro diagnostic manufacturers selling products to Middle East countries. IVD manufacturers can expect solid growth in developing countries, especially in the BRIC countries (Brazil, Russia, India, China), Southeast Asia and the Middle East (ME). But even in emerging markets, growth has slowed from earlier average annual growth figures of 20%.
Some of the total IVD market growth derives from increased test usage in emerging countries. In vitro diagnostic (IVD) companies are casting their nets in developing countries, where rising incomes and standards of living have sparked a new health consciousness and growing demands for quality medical care. The Middle East is an underserved region with large market potential. IVD in the Middle East provides data on the developments in the IVD industry in the Middle East, including:
Egypt In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Microbiology, POC, Histology, Other, Total)
Other Mideast In Vitro Diagnostic Sales by Market Segment, 2016-2021 (Clinical Chemistry, Microbiology, POC, Histology, Other, Total)
Mideast In Vitro Diagnostic Sales by Country, 2016-2021 (Egypt, Turkey, Saudi Arabia, United Arab Emirates, Israel, Jordan, Other Mideast, Total)
The countries covered are Egypt, Turkey, Saudi Arabia, United Arab Emirates (UAE), Israel, Jordan, and other Mideast (Bahrain, Gaza Strip, Iran, Iraq, Kuwait, Lebanon, Oman, Qatar, Syria, West Bank, Yemen).
The information presented in this report is derived on publicly available information sources such as company, government, and medical organization reports. The analysis is based on the author's industry knowledge combined with literature searches
Why the Middle East?
IVD companies are looking at all regions of course, but there's competition already in many areas where healthcare demand was detected long ago. There's competition in the Middle East as well, but the growth rate and spending increase looks good longer term. In the Middle East, with increased demand for healthcare has come increased access to it. In the 1970s, many countries in the Middle East and the Gulf countries started down a path to providing public healthcare to their citizens. Currently, Oman, Saudi Arabia, Qatar, Syria and Turkey all have universal healthcare programs. This development requires increased investment in healthcare. This increased investment most often takes the form of government tenders, which remain a major source of supply for state-controlled labs and hospitals. In the Middle East, lifestyle change - a more sedentary lifestyle resulting in rising obesity rates -- has brought about the emergence of “Western” diseases such as diabetes. There is growing demand in the region, therefore, for medical tests.
What is the Top Country?
There's no one country, as we see it. To focus on one would ignore a lot of demand, but you could say this - combined Saudi Arabia, Egypt and Turkey are half of the GDP in the Middle East. Their healthcare demand also makes them large markets and markets for specific products are detailed in the report.
How is Competition in the Middle East?
Brisk. Siemens and Beckman Coulter have office branches in Dubai's Healthcare City, a free enterprise zone authorized by the UAE. Abbott Diagnostics has offices in Egypt and Tel Aviv Israel. Abbott Diabetes Care has several offices and distributors and the Free Style product is a focus of diagnostic sales efforts in the region. Abbott maintains a Diabetes Care division in Jeddah, Saudi Arabia, and uses Pharma World, LLC in Dubai to distribute to the United Arab Emirates (UAE). Roche is heavily invested here as well. Roche's strategy has also involved expanding the company's commercial reach with the establish of the company's Management Center in Dubai for the Middle East, a commercial hub for some 20 countries in the region. Roche's goal has been to bring European standards in the supply and support of in-vitro diagnostics products to the region and make these high standards available to patients. Four years in, the company believes that, in many dimensions, this has been achieved.
The Arab Health Congress is an annual regional meeting that is indicative of the international nature of the participants in the Middle East market for healthcare, including IVD. Arab Health 2016, the 41st edition of the Arab Health meeting, was held in Dubai in January of 2016. Arab Health 2016 hosted a total of 4,187 exhibitors. The exhibitor breakdown by region was as follows: Europe, 47%; Asia, 32%; the Americas, 11%; Middle East, 8%; Africa, 1%; and Australasia, 1%. At 35 country pavilions were displayed a wide range of hospital medical equipment, devices, and technology.
We were unable to search inside this report.
No results matched your search criteria.
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend").
Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.